The DNA glycosylase MBD4 has been previously associated with somatic CpG hypermutation in AML and uveal melanoma (Sanders et al, 2018; The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, 2020); however, all patients developed tumours due to genetic predisposition. This evidence concerns the gene MBD4 and cancer.